Minimal residual disease (MRD) screening is crucial in lymphoma management as it predicts relapse risk and guides therapeutic decisions. Traditional MRD methods often involve invasive biopsies, leading to patient https://rebeccagyci276305.pointblog.net/liquid-biopsy-for-minimal-residual-disease-detection-in-lymphoma-84579304